HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Susan C Brown Selected Research

Cobblestone Lissencephaly

8/2012The dystrophin-glycoprotein complex in brain development and disease.
4/2004Defective glycosylation in congenital muscular dystrophies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Susan C Brown Research Topics

Disease

17Muscular Dystrophies (Muscular Dystrophy)
04/2014 - 03/2002
6Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy)
09/2011 - 03/2002
5Walker-Warburg Syndrome
01/2008 - 11/2002
3Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
01/2015 - 01/2003
3Rhabdomyolysis
03/2014 - 12/2008
3Intellectual Disability (Idiocy)
08/2012 - 11/2003
2Muscular Diseases (Myopathy)
03/2014 - 12/2008
2Malignant Hyperthermia
03/2014 - 01/2014
2Central Core Myopathy (Central Core Disease)
03/2014 - 01/2014
2Cobblestone Lissencephaly
08/2012 - 04/2004
2Group II Malformations of Cortical Development
08/2012 - 11/2002
2Emery-Dreifuss Muscular Dystrophy (Scapuloperoneal Muscular Dystrophy)
12/2008 - 09/2005
2Autosomal Emery-Dreifuss Muscular Dystrophy
04/2007 - 09/2005
2Type 2I Limb-Girdle Muscular Dystrophy
12/2005 - 02/2004
2Scleroatonic muscular dystrophy
01/2005 - 06/2004
1Inborn Genetic Diseases (Disease, Hereditary)
01/2014
1Minicore Myopathy with External Ophthalmoplegia
01/2014
1Congenital Structural Myopathies (Centronuclear Myopathy)
01/2014
1Cognitive Dysfunction
08/2012
1Myoclonic dystonia
08/2012
1Movement Disorders (Movement Disorder)
08/2012
1Disease Progression
10/2009
1Myopia
01/2008
1Muscle Weakness
01/2005
1Contracture
01/2005
1Eye Abnormalities (Eye Abnormality)
11/2003

Drug/Important Bio-Agent (IBA)

16Dystroglycans (Dystroglycan)IBA
01/2015 - 11/2002
9Proteins (Proteins, Gene)FDA Link
04/2014 - 11/2002
7GlycosyltransferasesIBA
12/2010 - 03/2002
4EnzymesIBA
12/2010 - 11/2002
3protein O-mannose beta-1,2-N-acetylglucosaminyltransferaseIBA
10/2009 - 11/2003
2CalciumIBA
03/2014 - 01/2014
2DystrophinIBA
08/2012 - 01/2003
2LaminsIBA
04/2007 - 09/2005
2CollagenIBA
01/2005 - 06/2004
1Pharmaceutical PreparationsIBA
01/2014
1Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
01/2014
1Dantrolene (Dantrium)FDA LinkGeneric
01/2014
1Glycoproteins (Glycoprotein)IBA
08/2012
1Sarcoglycans (beta Sarcoglycan)IBA
08/2012
1Lamin Type A (Lamin A)IBA
12/2008
1Polysaccharides (Glycans)IBA
12/2008
1emerinIBA
12/2008
1DesminIBA
04/2007
1SteroidsIBA
11/2006
1Creatine Kinase (Creatine Phosphokinase)IBA
11/2006
1Purinergic P2X4 ReceptorsIBA
03/2004
1Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA
01/2003
1Amino AcidsFDA Link
12/2002
1Mutant Proteins (Protein, Mutant)IBA
12/2002
1Muscle Proteins (Muscle Protein)IBA
11/2002